News 05.11.2021 MD Anderson and Ó³»´«Ã½ launch new translational research platform focused on rare cancers Joint initiative will develop comprehensive collection of molecularly and functionally characterized rare cancer tumor models to inform novel therapeutic strategies Cancer Program Cancer Cancer Dependency Map Read more
News 05.05.2021 Tumors hide from the immune system with help from this protein Called SETDB1, the protein could one day be targeted by new drugs for cancer patients who don’t respond to existing immunotherapies. Genome regulation, cell circuitry, and epigenomics Cancer Read more
News 04.21.2021 Researchers find genetic vulnerability in pediatric neuroblastoma Genetic screens point to NXT1 as a promising target for new pediatric cancer drugs. Cancer Program Cancer Cancer Dependency Map Read more
News 03.22.2021 Pediatric cancers have unique genetic vulnerabilities New map of genetic dependencies points to potential drug targets for childhood cancers. Cancer Program Cancer Cancer Dependency Map Read more
News 03.11.2021 A better understanding of the immune system in kidney cancer Two research papers highlight single-cell dissection of kidney tumors to identify new immunotherapy treatments and targets Cancer Program Cancer Single cell genomics Single Cell Read more
News 03.08.2021 New single-cell technology points to mechanism of cancer immunotherapy resistance Researchers used Perturb-CITE-seq to identify a protein involved in resistance to immune checkpoint inhibitors. Klarman Cell Observatory Regev Lab Cancer Gene-Expression Profiling Single Cell Aviv Regev Read more
News 02.22.2021 A call to action to build a better map of cancer’s genetic vulnerabilities Two cancer geneticists make the case for moving beyond tumor sequencing studies. Cancer Program Cancer Cancer Dependency Map Read more
News 02.16.2021 New immunotherapy target discovered for malignant brain tumors Study of T cells from glioma tumors identifies a pathway that inhibits immune response Genome regulation, cell circuitry, and epigenomics Klarman Cell Observatory Cancer Aviv Regev Read more
News 01.04.2021 Dependency Map team releases Celligner to help match tumors and cell lines for research New computational tool uses gene expression data to measure how closely laboratory cancer models compare to real tumors Cancer Program Cancer Cancer Dependency Map DepMap Read more
News 12.15.2020 New genetic vulnerability found in upwards of a third of all cancers Genetic screens point to VPS4A and VPS4B as promising cancer drug targets Cancer Program Cancer Dependency Map Cancer DepMap Read more